IPHA News

June 20, 2025

IPHA response to Sinn Féin’s Healthcare (Transparent Payments) Bill 2022 as disclosure rates continue to rise.

IPHA response to Sinn Féin’s Healthcare (Transparent Payments) Bill 2022 as disclosure rates continue to rise. Disclosure rates to named healthcare professionals for 2023 was 96%; 2024 […]
June 16, 2025

IPHA and cormeo join forces in mutual stewardship of medicines.ie – setting new standards in medicinal information distribution throughout Europe

Dublin, 16 June 2025 – The Irish Pharmaceutical Healthcare Association (IPHA) and cormeo, the newly established German based Pharma Tech holding company under Bertelsmann, announces its […]
May 20, 2025

IPHA calls for continued momentum and reform to ensure more patients can benefit from life-saving clinical trials.

20 May 2025 The Irish Pharmaceutical Healthcare Association (IPHA) welcomes encouraging progress in clinical trials activity in Ireland over the past year, as reported in its […]
May 7, 2025

Ireland has the lowest rate of availability for new cancer medicines in Western Europe, limiting treatment options for patients.

Ireland continues to rank among the bottom of Western European countries when it comes to availability of newly licensed cancer treatments, according to a new report by data analysts IQVIA for EFPIA, the European pharmaceutical body.
April 23, 2025

Urban Waste Water Treatment Directive (UWWTD)

The objective of Directive 91/271/EEC is to protect the environment from being adversely affected byinsufficiently treated urban wastewater discharges.
February 26, 2025

New research finds that patients in Ireland could get access to medicines one year earlier

Today, (Wednesday 26th February) the Irish Pharmaceutical Healthcare Association (IPHA) publishes a position paper on the 2025 Programme for Government Commitments which makes the case for Faster and Fairer Access to Medicines.
December 9, 2024

IPHA announces new website features highlighting our continuing commitment to compliance and transparency

The Irish Pharmaceutical Healthcare Association (IPHA), the representative body for the research-based biopharmaceutical industry in Ireland, has launched new features on the IPHA website which further […]
October 21, 2024

IPHA launches its Innovate For Life campaign 2024

Let’s give every patient in Ireland the chance to create new memories.    Pfizer, Novo Nordisk, Roche and AbbVie feature in IPHA’s campaign which highlights how, […]
October 1, 2024

Budget 2025: €30m for new medicines is significant for patients as it will allow for the continuous flow of new life-enhancing treatments

36 new IPHA medicines planned for 2025 has the potential to benefit up to 3,700 patients and funding will now ensure access to these advances in medicines […]